Back to Results
First PageMeta Content
Pharmaceutical sciences / Ipilimumab / Gilead Sciences / Melanoma / FactSet Research Systems / Food and Drug Administration / Aripiprazole / Medicine in China / Bristol-Myers Squibb / Medicine / Chemistry


Bristol-Myers earnings jump 27 percent, but stock falls
Add to Reading List

Document Date: 2015-05-15 20:57:34

Open Document

File Size: 15,95 KB

Share Result on Facebook

City

New York / /

Company

The Associated Press / Gilead Sciences Inc. / Wall Street / Bristol-Myers Squibb Co. / Flexus Biosciences Inc. / /

Country

United States / /

Currency

USD / cent / /

Event

Earnings Announcement / M&A / Product Release / /

IndustryTerm

bipolar disorder treatment / /

MarketIndex

S&P 500 / /

MedicalCondition

leukemia / newest cancer / cancer / HIV / schizophrenia / company's new melanoma / rheumatoid arthritis / attack skin cancer / heart disease / prostate and other cancers / advanced melanoma / diabetes / hepatitis C / Gilead Sciences Inc.'s blockbuster hepatitis C / melanoma / lung cancer / bipolar disorder / autoimmune diseases / /

Organization

U.S. Food and Drug Administration / /

Person

Abilify / Linda A. Johnson / A. Johnson Higher / /

Product

Opdivo / Orencia / Evotaz / Yervoy / Sprycel / Abilify / /

URL

www.tcpdf.org / http /

SocialTag